| Target Price | $11.37 |
| Price | $7.51 |
| Potential |
51.45%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Profound Medical Corp 2026 .
The average Profound Medical Corp target price is $11.37.
This is
51.45%
register free of charge
$11.71
55.90%
register free of charge
$11.26
49.96%
register free of charge
|
|
| A rating was issued by 6 analysts: 5 Analysts recommend Profound Medical Corp to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Profound Medical Corp stock has an average upside potential 2026 of
51.45%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 10.68 | 17.54 |
| 48.33% | 64.23% | |
| EBITDA Margin | -300.84% | -217.66% |
| 21.15% | 27.65% | |
| Net Margin | -260.49% | -255.55% |
| 34.35% | 1.90% |
5 Analysts have issued a sales forecast Profound Medical Corp 2025 . The average Profound Medical Corp sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Profound Medical Corp EBITDA forecast 2025. The average Profound Medical Corp EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Profound Medical Corp Analysts have issued a net profit forecast 2025. The average Profound Medical Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.12 | -1.48 |
| 17.04% | 32.14% | |
| P/E | negative | |
| EV/Sales | 11.49 |
5 Analysts have issued a Profound Medical Corp forecast for earnings per share. The average Profound Medical Corp EPS is
This results in the following potential growth metrics and future valuations:
Profound Medical Corp...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| LEEDE JONES GABLE |
Locked
➜
Locked
|
Locked | Aug 15 2025 |
| LEEDE JONES GABLE |
Locked
➜
Locked
|
Locked | May 09 2025 |
| LEEDE JONES GABLE |
Locked
➜
Locked
|
Locked | May 08 2025 |
| RAYMOND JAMES LTD. |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| RAYMOND JAMES LTD. |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
| RAYMOND JAMES LTD. |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
| RAYMOND JAMES LTD. |
Locked
➜
Locked
|
Locked | Dec 10 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
|
Aug 15 2025 |
|
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
|
May 09 2025 |
|
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
|
May 08 2025 |
|
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
|
Apr 29 2025 |
|
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
|
Apr 28 2025 |
|
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
|
Mar 05 2025 |
|
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
|
Dec 10 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


